Abstract
HTLV-I is an exogenous human retrovirus that is a causative agent of adult T cell leukemia (ATL). In addition to the structural genes (gag, pol and env), a gene termed pX is postulated to be associated with leukemogenesis in ATL. Since no effective chemotherapy is currently available, it is important to find suitable therapeutic means against ATL. Here, we tested the inhibitory effect of antisense oligodeoxynucleotides (ODNs) on HTLV-I infection in different systems. ODNs were synthesized with the phosphorothioate backbone targeted to either structural genes or transactivator genes. The phosphorothioate ODNs were found to have two distinct target sites to exert their effect on HTLV-I infection: 1) Several ODNs, including sense ODNs and random oligomers, blocked syncytium formation induced by HTLV-I at a concentration of 0.1 μM. Their inhibitory effect on syncytium formation seemed to be exerted in a nonantisense manner, most probably due to their interaction with the cell membrane. 2) Efficient suppression by ODNs of gag gene expression after chemical induction was observed in HTLV-I-transformed T cells in an antisense manner. In this suppression, tax-antisense ODN showed virtually complete inhibition of gag protein expression, but not RNA expression, at the concentration of 0.1 μM, whereas tax-sense ODN displayed a weak inhibitory effect. Our results suggest that the influence of the phosphorothioate compound should be considered from the aspect of two separated mechanisms of antiviral activity, the effects on early (viral adsorption) and late (translation) phase infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., and Gallo R.C., Proc Natl Acad Sci USA 77, 7415–7419, 1980.
Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K., Shirakawa S., and Miyoshi I., Proc Natl Acad Sci USA 78, 6476–6480, 1981.
Yoshida M., Miyoshi I., and Hinuma Y., Proc Natl Acad Sci USA 79, 2031–2035, 1982.
Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., and Calender A., Lancet 2, 407–410, 1985.
Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., and Igata A., Ann Neurol 21, 117–122, 1987.
Manns A. and Blattner W., Transfusion 31, 67–75, 1991.
Levine P.H., Jaffe E.S., Manns A., Murphy E.L., Clark J., and Blattner W.A., J Biol Med 61, 215–222, 1988.
Levine P.H., Blattner W.A., Clark J., Tarone R., Maloney E.M., Murphy E.M., Gallo R.C., Robert-Guroff M., and Saxinger W.C., Int J Cancer 42, 7–12, 1988.
Gallo R.C., Sci Am 255, 88–98, 1986.
Seiki M., Hattori S., Hirayama Y., and Yoshida M., Proc Natl Acad Sci USA 80, 3618–3622, 1983.
Yoshida M., Biochim Biophys Acta 907, 145–161, 1987.
Tanaka Y., Koyanagi Y., Chosa T., Yamamoto N., and Hinuma Y., Gann 74, 327–330, 1983.
Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., and Chen I.S., Cell 61, 213–222, 1990.
Kitajima I., Shinohara T., Minor T., Bibbs L., Bilakovics J., and Nerenberg M., J Biol Chem 267, 25881–25888, 1992.
Fujita M., Murata K., and Shiku H., Blood 84, 2591–2596, 1994.
Bridges S.H. and Sarver N., Lancet 345, 427–432, 1995.
Furuta R.A., Kubota S., Maki Y., Hattori T., and Hatanaka M., J Virol 69, 1591–1599, 1995.
Shibahara S., Mukai S., Morisawa H., Nakashima H., Kobayashi S., and Yamamoto N., Nucleic Acids Res 17, 239–252, 1989.
Miller P.S., McParland K.B., Jayaraman K., and Ts'o P.O., Biochemistry 20, 1874–1880, 1981.
Matsukura M., Shinozuka K., Zon G., Mitsuya H., Reitz M., Cohen J.S., and Broder S., Proc Natl Acad Sci USA 84, 7706–7710, 1987.
Agrawal S, Ikeuchi T., Sun D., Sarin P.S., Konopka A., Maize J., and Zamecnik P.C., Proc Natl Acad Sci USA 86, 7790–7794, 1989.
Nakashima H., Shoji Y., Kim S.G., Shimada J., Mizushima Y., Ito M., Yamamoto N., and Takaku H., Nucleic Acids Res 22, 5004–5010, 1994.
Nagy K., Clapham P., Cheingsong-Popov R., and Weiss R.A., Int J Cancer 32, 321–328, 1983.
Hoshino H., Shimoyama M., Miwa M., and Sugimura T., Proc Natl Acad Sci USA 80, 7337–7341, 1983.
Hayami M., Tsujimoto H., Komuro A., Hinuma Y., and Fujiwara K., Gann 75, 99–102, 1984.
Clapham P., Nagy K., Cheingsong-Popov R., Exley M., and Weiss R.A., Science 222, 1125–1127, 1983.
Hoxie J.A., Matthews D.M., and Clines D.B., Proc Natl Acad Sci USA 81, 7591–7595, 1984.
Miyoshi I., Yoshimoto I., Kubonishi H., Taguchi Y., Shiraishi Y., Ohtsuki Y., and Akagi T., Gann 72, 997–998, 1981.
Yamamoto N., Okada M., Koyanagi Y., Kannagi M., and Hinuma Y., Science 217, 737–739, 1982.
Popovic M., Lange-Wantzin G., Sarin P.S., Mann D., and Gallo R.C., Proc Natl Acad Sci USA 80, 5402–5406, 1983.
Okochi K., Sato H., and Hinuma Y., Vox Sang 46, 245–253, 1984.
Kim S.G., Suzuki Y., Nakashima H., Yamamoto N., and Takaku H., Biochem Biophys Res Commun 179, 1614–1619, 1991.
Stec W.J., Grajkowski A., Koziolkiewiez M., and Uznanski B., Nucleic Acids Res 19, 5883–5888, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyano-Kurosaki, N., Koyanagi, Y., Mizuguchi, M. et al. Inhibition of HTLV-I induction and virus-induced syncytia formation by oligodeoxynucleotides. Virus Genes 12, 205–217 (1996). https://doi.org/10.1007/BF00284641
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00284641